Semler Scientific, Inc. (SMLR)
USD 33.51
(-1.63%)
USD 33.51
(-1.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 68.18 Million USD | 20.28% |
| 2022 | 56.68 Million USD | 6.9% |
| 2021 | 53.02 Million USD | 37.36% |
| 2020 | 38.6 Million USD | 17.81% |
| 2019 | 32.76 Million USD | 52.47% |
| 2018 | 21.49 Million USD | 72.59% |
| 2017 | 12.45 Million USD | 67.5% |
| 2016 | 7.43 Million USD | 6.18% |
| 2015 | 7 Million USD | 92.6% |
| 2014 | 3.63 Million USD | 59.85% |
| 2013 | 2.27 Million USD | 89.66% |
| 2012 | 1.19 Million USD | 279.43% |
| 2011 | 316 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 15.9 Million USD | 5.63% |
| 2024 Q3 | 13.51 Million USD | -6.59% |
| 2024 Q2 | 14.46 Million USD | -9.04% |
| 2023 Q2 | 18.6 Million USD | 2.19% |
| 2023 Q1 | 18.2 Million USD | 31.98% |
| 2023 FY | 68.18 Million USD | 20.28% |
| 2023 Q4 | 15.05 Million USD | -7.72% |
| 2023 Q3 | 16.31 Million USD | -12.3% |
| 2022 Q3 | 14.04 Million USD | -5.27% |
| 2022 Q4 | 13.79 Million USD | -1.8% |
| 2022 Q1 | 14.01 Million USD | 21.43% |
| 2022 FY | 56.68 Million USD | 6.9% |
| 2022 Q2 | 14.82 Million USD | 5.79% |
| 2021 Q1 | 13.18 Million USD | 9.19% |
| 2021 Q4 | 11.54 Million USD | -17.5% |
| 2021 Q2 | 14.31 Million USD | 8.56% |
| 2021 FY | 53.02 Million USD | 37.36% |
| 2021 Q3 | 13.99 Million USD | -2.24% |
| 2020 Q1 | 9.43 Million USD | 3.05% |
| 2020 Q2 | 6.37 Million USD | -32.42% |
| 2020 Q4 | 12.07 Million USD | 12.55% |
| 2020 FY | 38.6 Million USD | 17.81% |
| 2020 Q3 | 10.72 Million USD | 68.32% |
| 2019 Q3 | 8.9 Million USD | 11.93% |
| 2019 Q2 | 7.95 Million USD | 17.63% |
| 2019 Q4 | 9.15 Million USD | 2.8% |
| 2019 Q1 | 6.76 Million USD | 13.36% |
| 2019 FY | 32.76 Million USD | 52.47% |
| 2018 FY | 21.49 Million USD | 72.59% |
| 2018 Q4 | 5.96 Million USD | 6.9% |
| 2018 Q3 | 5.57 Million USD | 1.73% |
| 2018 Q2 | 5.48 Million USD | 22.88% |
| 2018 Q1 | 4.46 Million USD | 5.93% |
| 2017 Q1 | 2.05 Million USD | -11.27% |
| 2017 Q2 | 2.57 Million USD | 25.45% |
| 2017 Q3 | 3.6 Million USD | 39.91% |
| 2017 Q4 | 4.21 Million USD | 16.8% |
| 2017 FY | 12.45 Million USD | 67.5% |
| 2016 Q1 | 1.5 Million USD | -48.84% |
| 2016 FY | 7.43 Million USD | 6.18% |
| 2016 Q4 | 2.31 Million USD | 16.85% |
| 2016 Q3 | 1.98 Million USD | 21.15% |
| 2016 Q2 | 1.63 Million USD | 8.99% |
| 2015 Q4 | 2.93 Million USD | 87.84% |
| 2015 Q3 | 1.56 Million USD | 19.88% |
| 2015 FY | 7 Million USD | 92.6% |
| 2015 Q2 | 1.3 Million USD | 8.4% |
| 2015 Q1 | 1.2 Million USD | 13.93% |
| 2014 Q1 | 837 Thousand USD | 7.17% |
| 2014 Q3 | 897 Thousand USD | 6.03% |
| 2014 Q4 | 1.05 Million USD | 17.61% |
| 2014 FY | 3.63 Million USD | 59.85% |
| 2014 Q2 | 846 Thousand USD | 1.08% |
| 2013 Q4 | 781 Thousand USD | 32.6% |
| 2013 Q1 | 429 Thousand USD | 0.47% |
| 2013 FY | 2.27 Million USD | 89.66% |
| 2013 Q2 | 475 Thousand USD | 10.72% |
| 2013 Q3 | 589 Thousand USD | 24.0% |
| 2012 Q3 | 311 Thousand USD | 0.0% |
| 2012 Q4 | 427 Thousand USD | 37.3% |
| 2012 FY | 1.19 Million USD | 279.43% |
| 2011 FY | 316 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -465.42% |
| BrainsWay Ltd. | 31.78 Million USD | -114.516% |
| Cerus Corporation | 156.36 Million USD | 56.395% |
| Envoy Medical, Inc. | 316 Thousand USD | -21477.215% |
| electroCore, Inc. | 16.03 Million USD | -325.352% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -10487.578% |
| IceCure Medical Ltd | 3.22 Million USD | -2011.614% |
| Inogen, Inc. | 315.66 Million USD | 78.4% |
| OrthoPediatrics Corp. | 148.73 Million USD | 54.156% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -2708.237% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -18580.599% |
| MaxCyte, Inc. | 41.28 Million USD | -65.142% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -3392.244% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -61466.8% |
| Orthofix Medical Inc. | 746.64 Million USD | 90.868% |
| PAVmed Inc | 2.45 Million USD | -2680.75% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -202.784% |
| RxSight, Inc. | 89.07 Million USD | 23.455% |
| Sight Sciences, Inc. | 81.05 Million USD | 15.88% |
| SI-BONE, Inc. | 138.88 Million USD | 50.906% |
| TELA Bio, Inc. | 58.45 Million USD | -16.648% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 63.561% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -394.051% |
| Acutus Medical, Inc. | 7.16 Million USD | -851.759% |
| Talis Biomedical Corporation | 412 Thousand USD | -16449.515% |
| Spectral AI, Inc. | 18.05 Million USD | -277.625% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -588.38% |
| CVRx, Inc. | 39.29 Million USD | -73.518% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -6938.668% |
| Bioventus Inc. | 512.34 Million USD | 86.692% |
| Venus Concept Inc. | 76.35 Million USD | 10.7% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -268.343% |
| LivaNova PLC | 1.15 Billion USD | 94.089% |
| 908 Devices Inc. | 50.22 Million USD | -35.746% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 85.862% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -88400.078% |
| NeuroPace, Inc. | 65.42 Million USD | -4.223% |
| LENSAR, Inc. | 42.16 Million USD | -61.711% |
| Apyx Medical Corporation | 52.34 Million USD | -30.249% |
| Cutera, Inc. | 212.36 Million USD | 67.894% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -104.401% |
| BioSig Technologies, Inc. | 18 Thousand USD | -378700.0% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 59.088% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -184.634% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 95.577% |
| Axonics, Inc. | 366.37 Million USD | 81.39% |
| Outset Medical, Inc. | 130.37 Million USD | 47.702% |
| IRIDEX Corporation | 51.86 Million USD | -31.454% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 49.935% |
| IRadimed Corporation | 65.56 Million USD | -3.999% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -5697.959% |
| INVO Bioscience, Inc. | 3.02 Million USD | -2157.319% |
| Telesis Bio, Inc. | 27.5 Million USD | -147.861% |
| Viemed Healthcare, Inc. | 183 Million USD | 62.743% |
| Varex Imaging Corporation | 811 Million USD | 91.593% |
| Quipt Home Medical Corp. | 221.74 Million USD | 69.251% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 0.715% |
| Dynatronics Corporation | 32.53 Million USD | -109.578% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -685.711% |
| InMode Ltd. | 492.04 Million USD | 86.143% |
| Bruker Corporation | 2.96 Billion USD | 97.7% |
| Cytosorbents Corporation | 36.34 Million USD | -87.58% |
| DexCom, Inc. | 3.62 Billion USD | 98.118% |
| Align Technology, Inc. | 3.86 Billion USD | 98.235% |
| Viveve Medical, Inc. | 6.42 Million USD | -961.064% |
| ZimVie Inc. | 457.43 Million USD | 85.094% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 64.674% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -61466.8% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 90.881% |
| Profound Medical Corp. | 7.33 Million USD | -830.075% |
| Insulet Corporation | 1.69 Billion USD | 95.982% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 45.919% |
| iCAD, Inc. | 17.31 Million USD | -293.718% |
| Nuwellis, Inc. | 8.86 Million USD | -669.224% |
| Biotricity, Inc. | 12.06 Million USD | -465.216% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 86.161% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -998.856% |
| PAVmed Inc. | 2.45 Million USD | -2680.75% |
| BIOLASE, Inc. | 49.16 Million USD | -38.687% |
| Beyond Air, Inc. | 1.15 Million USD | -5783.003% |
| FONAR Corporation | 102.88 Million USD | 33.727% |
| AxoGen, Inc. | 159.01 Million USD | 57.12% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 75.154% |
| Inari Medical, Inc. | 493.63 Million USD | 86.187% |
| UFP Technologies, Inc. | 400.07 Million USD | 82.957% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -366480.645% |
| Tenon Medical, Inc. | 2.92 Million USD | -2228.689% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -900.934% |
| AdaptHealth Corp. | 3.2 Billion USD | 97.869% |
| Sintx Technologies, Inc. | 2.62 Million USD | -2495.508% |
| NanoVibronix, Inc. | 2.28 Million USD | -2886.597% |
| Quanterix Corporation | 122.36 Million USD | 44.28% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -179.385% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 65.997% |
| TransMedics Group, Inc. | 241.62 Million USD | 71.781% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -392.161% |
| NeuroMetrix, Inc. | 5.9 Million USD | -1055.382% |
| Hyperfine, Inc. | 11.03 Million USD | -518.057% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 58.714% |
| Biomerica, Inc. | 5.41 Million USD | -1159.169% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -34.855% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 61.507% |